Skip to main content
AMP 2023 Annual Meeting & Expo Main banner
Final Program


Icon Legend
Presentation Icons
Platinum Award
Platinum Award
Gold Award
Gold Award
Silver Award
Silver Award
Bronze Award
Bronze Award

  1. Home

  • Thursday, Nov 16th
    10:15 AM - 11:45 AM MST
    Genomic Subclassification of Acute Lymphoblastic Leukemia: Cutting Edge Approaches and Practical Considerations
    Location: 355BC, Third Level
    Co-Moderator: Nathan Montgomery, MD, PhD – NeoGenomics
    Co-Moderator (Early Career): Erica Vormittag-Nocito, MD – Northwestern University
    OncologyMolecular Methodologies & Technologies
     CE: 1.50
  • Thursday, Nov 16th
    10:15 AM - 11:00 AM MST
    Genomic Subclassification of Acute Lymphoblastic Leukemia Using Whole Transcriptome Sequencing and Whole Genome Sequencing
    Location: 355BC, Third Level
    Speaker: Charles G. Mullighan, MBBS (Hons), MSc, MD – St. Jude Children's Research Hospital
    OncologyMolecular Methodologies & Technologies
     CE: 1.50
  • Thursday, Nov 16th
    11:00 AM - 11:45 AM MST
    Practical Approaches to Acute Lymphoblastic Leukemia Classification
    Location: 355BC, Third Level
    Speaker: Marian Harris, MD, PhD – Harvard Medical School
    OncologyMolecular Methodologies & Technologies
     CE: 1.50
  • Thursday, Nov 16th
    2:30 PM - 3:00 PM MST
    AMP Working Group: Tumor Mutational Burden Assay Validation and Reporting
    Location: 250, Upper Concourse
    Speaker: Larissa V. Furtado, MD – St. Jude Children’s Research Hospital
    OncologyMolecular Methodologies & Technologies
     CE: 1.0
  • Thursday, Nov 16th
    3:00 PM - 3:30 PM MST
    Panel Discussion: AMP Working Group: Tumor Mutational Burden Assay Validation and Reporting
    Location: 250, Upper Concourse
    Panelist: Larissa V. Furtado, MD – St. Jude Children’s Research Hospital
    Panelist: Susan Hsiao, MD, PhD – Columbia University Medical Center
    Panelist: Jonathan A. Nowak, MD, PhD – Brigham and Women's Hospital
    OncologyMolecular Methodologies & Technologies
     CE: 1.0
  • Thursday, Nov 16th
    5:00 PM - 6:00 PM MST
    Methylation Based Classification of Human Tumors
    Location: Grand Ballroom, Lower Concourse
    Speaker: Andreas von Deimling, MD (he/him/his) – Dept Neuropathology University Hospital Heidelberg, CCU Neuropathology, German Cancer Center DKFZ
    Oncology
     CE: 1.0
  • Friday, Nov 17th
    8:15 AM - 9:15 AM MST
    Genetic Classification and Risk-Stratification of Myeloid Neoplasia
    Location: Grand Ballroom, Lower Concourse
    Co-Moderator: Nathan Montgomery, MD, PhD – NeoGenomics
    Co-Moderator: Craig Soderquist, MD – Columbia University
    Oncology
     CE: 1.0
  • Friday, Nov 17th
    8:15 AM - 9:15 AM MST
    New Insights into Molecular Pathogenesis and Clonal Evolution in AML
    Location: Grand Ballroom, Lower Concourse
    Speaker: Ross Levine, MD – Memorial Sloan Kettering
    Oncology
     CE: 1.0
  • Friday, Nov 17th
    10:15 AM - 11:45 AM MST
    Clonal But Not Malignant Disease Processes in Hematopathology: VEXAS, PNH, and Aplastic Anemia
    Location: 255BC, Second Level
    Co-Moderator: Nathan Montgomery, MD, PhD – NeoGenomics
    Co-Moderator (Early Career): Richard Wong, MD, PhD – University of California San Diego
    Oncology
     CE: 1.50
  • Friday, Nov 17th
    10:15 AM - 11:45 AM MST
    Recommendations for Cell-Free DNA Assay Validations: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists
    Location: 251, Upper Concourse
    Co-Moderator: Deepika Sirohi, MD – University of California
    Co-Moderator: Susan Hsiao, MD, PhD – Columbia University Medical Center
    OncologyInformaticsMolecular Methodologies & Technologies
     CE: 1.50
  • Friday, Nov 17th
    10:15 AM - 11:00 AM MST
    Clonal But Not Malignant Disease Processes in Hematopathology: VEXAS, PNH, and Aplastic Anemia
    Location: 255BC, Second Level
    Oncology
     CE: 1.50
  • Friday, Nov 17th
    10:15 AM - 11:45 AM MST
    Recommendations for Cell-Free DNA Assay Validations: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists
    Location: 251, Upper Concourse
    Speaker: Christina Lockwood, PhD (she/her/hers) – University of Washington
    OncologyInformaticsMolecular Methodologies & Technologies
     CE: 1.50
  • Friday, Nov 17th
    11:00 AM - 11:45 AM MST
    Decoding Somatic Genetic Changes in Aplastic Anemia: Diagnostic and Prognostic Significance
    Location: 255BC, Second Level
    Speaker: Daria Babushok, MD PhD – University of Pennsylvania
    Oncology
     CE: 1.50
  • Friday, Nov 17th
    1:15 PM - 2:00 PM MST
    Spatial Genomics in Solid Tumors
    Location: 251, Upper Concourse
    Speaker: Andrew Gentles, PhD – Stanford Pathology, Medicine (Biomedical Informatics) and Biomedical Data Science
    OncologyMolecular Methodologies & Technologies
     CE: 1.50
  • Friday, Nov 17th
    2:00 PM - 2:45 PM MST
    The Spatially Resolved Tumor Microenvironment of Hodgkin Lymphoma
    Location: 251, Upper Concourse
    Speaker: Christian Steidl, MD (he/him/his) – The University of British Columbia
    OncologyMolecular Methodologies & Technologies
     CE: 1.50
  • Saturday, Nov 18th
    8:15 AM - 9:15 AM MST
    DNA Hypomethylation Restrains Malignant Progression
    Location: Grand Ballroom, Lower Concourse
    Speaker: Sarah Johnstone, MD, PhD – Dana-Farber Cancer Institute
    OncologyInherited Conditions
     CE: 1.0
  • Saturday, Nov 18th
    1:15 PM - 1:45 PM MST
    AMP Working Group: Provider-Friendly Molecular Biomarker Reports
    Location: 251, Upper Concourse
    Speaker: Jane Gibson, PhD (she/her/hers) – Univ of Central Florida College of Medicine
    OncologyLab Management
  • Saturday, Nov 18th
    1:45 PM - 2:15 PM MST
    Panel Discussion for Working Group: Provider-Friendly Molecular Biomarker Reports
    Location: 251, Upper Concourse
    Panelist: Jane Gibson, PhD (she/her/hers) – Univ of Central Florida College of Medicine
    Panelist: Noah Brown – University of Michgian
    Panelist: Joshua Coleman, MD (he/him/his) – University of Utah
    Panelist: Jennifer Laudadio, MD (she/her/hers) – University of Arkansas for Medical Sciences
    Panelist: Christopher G. Suciu, MD, AP/CP, MGP, CI – OHSU
    OncologyLab Management
  • Saturday, Nov 18th
    2:30 PM - 3:15 PM MST
    Molecular Characterization and Classification of Aggressive B-Cell Lymphomas
    Location: 355BC, Third Level
    Speaker: Margaret Shipp, MD (she/her/hers) – Dana-Farber Cancer Institute
    OncologyMolecular Methodologies & Technologies
     CE: 1.50
  • Saturday, Nov 18th
    3:15 PM - 4:00 PM MST
    A Practical Approach to Molecular Testing in Aggressive B-Cell Lymphoma
    Location: 355BC, Third Level
    Speaker: Rena R. Xian, MD (she/her/hers) – Johns Hopkins University School of Medicine
    OncologyMolecular Methodologies & Technologies
     CE: 1.50
  • Saturday, Nov 18th
    4:15 PM - 4:45 PM MST
    Guidelines and Standards for Classification, Interpretation and Reporting of Somatic Sequence Variants in Cancer
    Location: 250, Upper Concourse
    Speaker: Peter Horak, MD, PhD – National Center For Tumor Diseases
    OncologyMolecular Methodologies & Technologies
     CE: 1.0
  • Saturday, Nov 18th
    4:45 PM - 5:15 PM MST
    Standardized Nomenclature in Reporting Sequence Variants in Cancer
    Location: 250, Upper Concourse
    Speaker: Wesley Goar, PhD (he/him/his) – Nationwide Children's Hospital
    OncologyMolecular Methodologies & Technologies
     CE: 1.0